EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Potential of Deferiprone–Resveratrol Hybrid (DFP-RVT) Against Hepatic Iron Overload in β-Thalassemia Mice: A Proteomic Analysis

Supawadee Maneekesorn, Yodying Yingchutrakul iD, Nattapon Simanon iD, Jakkaphan Kumsab, Chutikarn Butkinaree iD, Sutpirat Moonmuang, Jin Li iD, Pimlak Charoenkwan iD, Pimpisid Koonyosying iD, Narisara Paradee, Somdet Srichairatanakool iD, Hataichanok Chuljerm

Biomolecules · 2026

DOI: 10.3390/biom16020338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Supawadee Maneekesorn und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: beta-Thalassemia, Deferiprone, Iron Overload, Proteomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation, Thailand Science Research and Innovation, Distinguished Professor Grant, National Research Council of Thailand, National Research Council of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron overload is a major pathological feature of β-thalassemia and a key driver of hepatic injury through oxidative stress and mitochondrial dysfunction. This study investigated the molecular effects of iron overload on liver mitochondria and evaluated the therapeutic potential of a deferiprone–resveratrol hybrid (DFP-RVT) in a β-thalassemia mouse model. Proteomic analysis was performed on liver tissues from baseline control, iron-overloaded, and DFP-RVT-treated mice to identify differentially expressed proteins and affected pathways. Iron overload resulted in marked downregulation of mitochondrial proteins, particularly components of oxidative phosphorylation and iron–sulfur cluster-associated pathways, including frataxin. In contrast, DFP-RVT treatment restored the expression of multiple mitochondrial proteins involved in respiratory chain function and energy metabolism. Comparative proteomic profiling revealed opposing regulation patterns between iron-overloaded and DFP-RVT-treated groups, indicating recovery of mitochondrial integrity following iron chelation therapy. These findings suggest that iron-induced hepatic injury in β-thalassemia is closely linked to mitochondrial protein dysregulation and that DFP-RVT may mitigate this process by restoring mitochondrial protein expression and iron homeostasis. This study provides mechanistic insight into iron-mediated mitochondrial dysfunction and supports the therapeutic potential of DFP-RVT for iron overload-associated liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaDeferiproneIron OverloadProteomicsResveratrolAnimalsMiceLiverIron Chelating AgentsIronDisease Models, AnimalMaleMitochondria, LiverMitochondrial ProteinsOxidative Stress

Stichwörter der Autor:innen

frataxiniron chelation therapyiron overloadmitochondrial dysfunctionproteomicsβ-thalassemia

Substanzen

DeferiproneResveratrolIron Chelating AgentsIronMitochondrial Proteins

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Thalassemia and Hematology Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Khlong Luang, Pathum Thani 12120, Thailand.
  • Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Department of Biochemistry, Faculty of Medicine, Youjiang Medical University for Nationalities, Baise 533000, China.

ORCID-Profile: Yodying Yingchutrakul, Nattapon Simanon, Chutikarn Butkinaree, Jin Li, Pimlak Charoenkwan, Pimpisid Koonyosying, Somdet Srichairatanakool

Förderung

  • Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation, Thailand Science Research and Innovation
  • Distinguished Professor Grant, National Research Council of Thailand
  • National Research Council of Thailand

Zitieren

APA

Maneekesorn, S., Yingchutrakul, Y., Simanon, N., Kumsab, J., Butkinaree, C., Moonmuang, S., Li, J., Charoenkwan, P., Koonyosying, P., Paradee, N., Srichairatanakool, S., & Chuljerm, H. (2026). Therapeutic Potential of Deferiprone–Resveratrol Hybrid (DFP-RVT) Against Hepatic Iron Overload in β-Thalassemia Mice: A Proteomic Analysis. Biomolecules. https://doi.org/10.3390/biom16020338

Vancouver

Maneekesorn S, Yingchutrakul Y, Simanon N, Kumsab J, Butkinaree C, Moonmuang S, et al. Therapeutic Potential of Deferiprone–Resveratrol Hybrid (DFP-RVT) Against Hepatic Iron Overload in β-Thalassemia Mice: A Proteomic Analysis. Biomolecules. 2026. doi:10.3390/biom16020338

BibTeX
@article{Maneekesorn2026,
  author = {Maneekesorn, Supawadee and Yingchutrakul, Yodying and Simanon, Nattapon and Kumsab, Jakkaphan and Butkinaree, Chutikarn and Moonmuang, Sutpirat and Li, Jin and Charoenkwan, Pimlak and Koonyosying, Pimpisid and Paradee, Narisara and Srichairatanakool, Somdet and Chuljerm, Hataichanok},
  title = {Therapeutic Potential of Deferiprone–Resveratrol Hybrid (DFP-RVT) Against Hepatic Iron Overload in β-Thalassemia Mice: A Proteomic Analysis},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16020338}
}
Kostenlos starten →